The U.S. Food and Drug Administration (FDA) has ordered manufacturers of certain prescription sleep aids, including Ambien, to strengthen their product labeling to include stronger language concerning potential risks -- including the risk of "sleep-driving" episodes. According to the FDA, "sleep driving" is defined as driving while not fully awake after taking sleep aid medication, with no memory of the event.
- Read the FDA Press Release
- From the Associated Press: FDA Warns of Sleeping Pill Side Effects
- Ambien Information and Resources (FindLaw)